QIAGEN’s careHPV™ Test Wins WHO Prequalification Status for Cervical Cancer Screening
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Qiagen NV (QGEN) PT Raised to $39.50 at Evercore ISI
August 1, 2018 12:13 PM EDTEvercore ISI analyst Ross Muken raised the price target on Qiagen NV (NYSE: QGEN) to $39.50 (from $38.00) while maintaining an Outperform rating following results.
... More